Clinical genetics of amyotrophic lateral sclerosis: what do we really know? - PubMed (original) (raw)
Review
. 2011 Oct 11;7(11):603-15.
doi: 10.1038/nrneurol.2011.150.
Affiliations
- PMID: 21989245
- DOI: 10.1038/nrneurol.2011.150
Review
Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
Peter M Andersen et al. Nat Rev Neurol. 2011.
Abstract
Hereditary amyotrophic lateral sclerosis (ALS) encompasses a group of genetic disorders characterized by adult-onset loss of the lower and upper motor neuron systems, often with involvement of other parts of the nervous system. Cases of hereditary ALS have been attributed to mutations in 12 different genes, the most common being SOD1, FUS and TARDBP-mutations in the other genes are rare. The identified genes explain 25-35% of cases of familial ALS, but identifying the remaining genes has proved difficult. Only a few genes seem to account for significant numbers of ALS cases, with many others causing a few cases each. Hereditary ALS can be inherited in an autosomal dominant, autosomal recessive or X-linked manner, and families with low disease penetrance are frequently observed. In such families, the genetic predisposition may remain unnoticed, so many patients carry a diagnosis of isolated or sporadic ALS. The only clinical feature that distinguishes recognized hereditary from apparently sporadic ALS is a lower mean age of onset in the former. All the clinical features reported in hereditary cases (including signs of extrapyramidal, cerebellar or cognitive involvement) have also been observed in sporadic cases. Genetic counseling and risk assessment in relatives depend on establishing the specific gene defect and the disease penetrance in the particular family.
Similar articles
- Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.
Hou L, Jiao B, Xiao T, Zhou L, Zhou Z, Du J, Yan X, Wang J, Tang B, Shen L. Hou L, et al. Sci Rep. 2016 Sep 8;6:32478. doi: 10.1038/srep32478. Sci Rep. 2016. PMID: 27604643 Free PMC article. - FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, Blumbergs PC, Vucic S, Kiernan MC, Nicholson GA. Blair IP, et al. J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):639-45. doi: 10.1136/jnnp.2009.194399. Epub 2009 Dec 3. J Neurol Neurosurg Psychiatry. 2010. PMID: 19965854 - [What is the role of the genetic survey in amyotrophic lateral sclerosis?].
Camu W. Camu W. Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S91-4S95. Rev Neurol (Paris). 2006. PMID: 17128094 French. - De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China.
Zou ZY, Cui LY, Sun Q, Li XG, Liu MS, Xu Y, Zhou Y, Yang XZ. Zou ZY, et al. Neurobiol Aging. 2013 Apr;34(4):1312.e1-8. doi: 10.1016/j.neurobiolaging.2012.09.005. Epub 2012 Oct 6. Neurobiol Aging. 2013. PMID: 23046859 - Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.
Yousefian-Jazi A, Seol Y, Kim J, Ryu HL, Lee J, Ryu H. Yousefian-Jazi A, et al. Cells. 2020 Dec 15;9(12):2687. doi: 10.3390/cells9122687. Cells. 2020. PMID: 33333804 Free PMC article. Review.
Cited by
- The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey.
Turner MR, Swash M. Turner MR, et al. J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):667-73. doi: 10.1136/jnnp-2014-308946. Epub 2015 Feb 2. J Neurol Neurosurg Psychiatry. 2015. PMID: 25644224 Free PMC article. Review. - Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications.
Mayer C, Riera-Ponsati L, Kauppinen S, Klitgaard H, Erler JT, Hansen SN. Mayer C, et al. Front Pharmacol. 2024 Jul 25;15:1437939. doi: 10.3389/fphar.2024.1437939. eCollection 2024. Front Pharmacol. 2024. PMID: 39119604 Free PMC article. Review. - Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis.
Gao J, Sterling E, Hankin R, Sikal A, Yao Y. Gao J, et al. Biomolecules. 2024 Jul 22;14(7):878. doi: 10.3390/biom14070878. Biomolecules. 2024. PMID: 39062592 Free PMC article. Review. - Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron disease.
Heiman-Patterson TD, Blankenhorn EP, Sher RB, Jiang J, Welsh P, Dixon MC, Jeffrey JI, Wong P, Cox GA, Alexander GM. Heiman-Patterson TD, et al. PLoS One. 2015 Mar 12;10(3):e0117848. doi: 10.1371/journal.pone.0117848. eCollection 2015. PLoS One. 2015. PMID: 25763819 Free PMC article. - Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS.
Steinberg KM, Yu B, Koboldt DC, Mardis ER, Pamphlett R. Steinberg KM, et al. Sci Rep. 2015 Mar 16;5:9124. doi: 10.1038/srep09124. Sci Rep. 2015. PMID: 25773295 Free PMC article.
References
- Nat Genet. 2004 Mar;36(3):225-7 - PubMed
- Mech Ageing Dev. 1990 Sep;55(3):207-20 - PubMed
- Nat Genet. 2006 Apr;38(4):411-3 - PubMed
- J Neurol Sci. 2004 Dec 15;227(1):27-33 - PubMed
- Neurology. 2009 Jan 20;72(3):287-8 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous